News Image

Uncovering Dividend Opportunities with NYSE:PFE.

By Mill Chart

Last update: Nov 23, 2023

Our stock screener has singled out PFIZER INC (NYSE:PFE) as a promising choice for dividend investors. NYSE:PFE not only scores well in profitability, solvency, and liquidity but also offers a decent dividend. We'll explore this further.

Unpacking NYSE:PFE's Dividend Rating

ChartMill employs its own Dividend Rating system for all stocks. This score, on a scale of 0 to 10, is determined by evaluating different dividend factors, such as yield, historical performance, dividend growth, and sustainability. NYSE:PFE has been assigned a 7 for dividend:

  • With a Yearly Dividend Yield of 5.51%, PFE is a good candidate for dividend investing.
  • PFE's Dividend Yield is rather good when compared to the industry average which is at 4.81. PFE pays more dividend than 97.56% of the companies in the same industry.
  • PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.65.
  • PFE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • PFE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.

Understanding NYSE:PFE's Health

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:PFE has received a 6 out of 10:

  • PFE has a Altman-Z score of 2.43. This is in the better half of the industry: PFE outperforms 72.20% of its industry peers.
  • With an excellent Debt to FCF ratio value of 7.78, PFE belongs to the best of the industry, outperforming 82.44% of the companies in the same industry.
  • A Current Ratio of 2.38 indicates that PFE has no problem at all paying its short term obligations.
  • A Quick Ratio of 2.05 indicates that PFE has no problem at all paying its short term obligations.

Profitability Assessment of NYSE:PFE

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NYSE:PFE, the assigned 8 is noteworthy for profitability:

  • PFE's Return On Assets of 4.87% is amongst the best of the industry. PFE outperforms 87.80% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.81%, PFE belongs to the top of the industry, outperforming 88.29% of the companies in the same industry.
  • PFE has a Return On Invested Capital of 5.70%. This is amongst the best in the industry. PFE outperforms 85.85% of its industry peers.
  • The 3 year average ROIC (16.16%) for PFE is well above the current ROIC(5.70%). The reason for the recent decline needs to be investigated.
  • PFE's Profit Margin of 15.29% is amongst the best of the industry. PFE outperforms 88.78% of its industry peers.
  • PFE's Operating Margin of 16.76% is amongst the best of the industry. PFE outperforms 86.34% of its industry peers.
  • In the last couple of years the Operating Margin of PFE has grown nicely.
  • With a decent Gross Margin value of 59.32%, PFE is doing good in the industry, outperforming 69.76% of the companies in the same industry.

Every day, new Best Dividend stocks can be found on ChartMill in our Best Dividend screener.

Our latest full fundamental report of PFE contains the most current fundamental analsysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

PFIZER INC

NYSE:PFE (2/28/2024, 2:32:05 PM)

27.135

+0.25 (+0.91%)

PFE News

News Image2 hours ago - ChartmillStay informed about the most active stocks in the S&P500 index on Wednesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session.

News Image3 hours ago - InvestorPlace3 Starter Long-Term Stocks Every New Investor Should Own

These three long-term stocks for new investors provide a solid foundation, harmonizing risk with rewarding prospects for the long haul.

News Image6 hours ago - InvestorPlace3 Forgotten Dividend Stocks With a Yield of Over 5%

These are the undervalued dividend stocks to buy as they represent fundamentally strong companies poised for accelerated growth.

News Image6 hours ago - InvestorPlace7 Dividend Stocks to Buy to Secure Steady Income

Unlock financial growth with 7 standout dividend stocks in real estate, industrial, pharma, and telecom sectors for long-term success.

News Image7 hours ago - CNBCThe pet drugs vets are now prescribing look a lot more like human medications

New drug treatment options are coming for cats and dogs as the divide between animal and human health is starting to narrow.

News Image8 hours ago - Yahoo FinanceUPDATE 1-Novavax sees 2024 sales flat to lower, aims to pick up COVID vaccine market share

The company posted a larger-than-expected fourth-quarter loss as revenue lagged analysts' estimates, sending its shares down 20% in volatile premarket trading. Chief Executive John Jacobs said Novavax claimed just a low-single-digit percentage market share in the U.S. during the most recent vaccination campaign, as demand for COVID vaccines was smaller than hoped and the company got its protein-based shot to market later than its messenger RNA-based rivals. The company posted a fourth-quarter loss of $1.44 a share on revenue of $291 million.

News Image8 hours ago - Yahoo FinanceNovavax sees 2024 sales flat to lower, aims to pick up COVID vaccine market share

The company posted a larger-than-expected fourth-quarter loss as revenue lagged analysts' estimates, sending its shares down 20% in volatile premarket trading. Chief Executive John Jacobs said Novavax claimed just a low-single-digit percentage market share in the U.S. during the most recent vaccination campaign, as demand for COVID vaccines was smaller than hoped and the company got its protein-based shot to market later than its messenger RNA-based rivals. The company posted a fourth-quarter loss of $1.44 a share on revenue of $291 million.

News Imagea day ago - InvestorPlace3 Overextended Stocks That Need to Slash Their Dividends ASAP

The most common attribute of overextended stocks other than carrying too much debt is dividends that are too big.

News Imagea day ago - ChartmillWhat's going on in today's session: S&P500 most active stocks

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for the market.

News Imagea day ago - Seeking AlphaBeam stock jumps as Eli Lilly deal brings Q4 beat (NASDAQ:BEAM)

Beam Therapeutics (BEAM) stock gains as the company reports profits in Q4 after boosting revenue thanks to a collaboration deal with Eli Lilly (LLY). Read more here.

News Imagea day ago - Market News VideoJune 2026 Options Now Available For Pfizer (PFE)
News Imagea day ago - The Motley FoolPfizer Stock Has 30% Upside, According to 1 Wall Street Analyst

Income investors can enjoy the nearly 6% dividend yield even if growth doesn't return.

PFE Links
Follow us for more